Although high-grade UTUC was the least frequent subgroup to have a KDM6A mutation, the frequency was still around 20%; whereas the frequency of mutated CREBBP accounted for 16% of all the UC cases. This evidence concerns the gene KDM6A and renal pelvis/ureter urothelial carcinoma.